More severe reactions were rare: one BRAF-mutated patient experienced grade 3 pyrexia, which resolved after a 2-day treatment interruption, and one BRAF wild-type patient developed a transient grade 4 skin rash three days post-therapy completion. The gene discussed is BRAF; the disease is Fever.